198 related articles for article (PubMed ID: 1995311)
21. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
[TBL] [Abstract][Full Text] [Related]
22. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523
[TBL] [Abstract][Full Text] [Related]
23. The suppressive effect of cyclophosphamide on low-dose streptozotocin-induced diabetes in mice.
Yanagawa T; Maruyama T; Takei I; Asaba Y; Takahashi T; Ishii T; Kataoka K; Saruta T; Minoshima S; Shimizu N
Diabetes Res; 1989 Oct; 12(2):79-83. PubMed ID: 2699444
[TBL] [Abstract][Full Text] [Related]
24. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
Sihvola M; Hurme M
J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
[TBL] [Abstract][Full Text] [Related]
25. NTP Toxicology and Carcinogenesis Studies of Benzyl Acetate (CAS No. 140-11-4) in F344/N Rats and B6C3F1 Mice Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 431():1-285. PubMed ID: 12616300
[TBL] [Abstract][Full Text] [Related]
26. Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity.
Fisher B; Wolmark N
Cancer Res; 1976 Jul; 36(7 PT 1):2241-7. PubMed ID: 1277129
[TBL] [Abstract][Full Text] [Related]
27. NTP Toxicology and Carcinogenesis Studies of Triamterene (CAS No. 396-01-0) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Dec; 420():1-367. PubMed ID: 12616291
[TBL] [Abstract][Full Text] [Related]
28. NTP Toxicology and Carcinogenesis Studies of t-Butylhydroquinone (CAS No. 1948-33-0) in F344/N Rats and B6C3F(1) Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 459():1-326. PubMed ID: 12587017
[TBL] [Abstract][Full Text] [Related]
29. NTP technical report on toxicity studies of t-butyl alcohol (CAS No. 75-65-0). Administered by inhalation to F344/N rats and B6C3F1 mice.
Mahler J
Toxic Rep Ser; 1997 Jul; (53):1-56, A1-D9. PubMed ID: 11803704
[TBL] [Abstract][Full Text] [Related]
30. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
31. Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice.
Nilsson C; Forsman J; Hassan Z; Abedi-Valugerdi M; O'Connor C; Concha H; Jansson M; Hassan M
Exp Hematol; 2005 Mar; 33(3):380-7. PubMed ID: 15730862
[TBL] [Abstract][Full Text] [Related]
32. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.
Chan PC
Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705
[TBL] [Abstract][Full Text] [Related]
33. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
Dunnick J
Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
[TBL] [Abstract][Full Text] [Related]
34. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
35. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
[TBL] [Abstract][Full Text] [Related]
36. [In vitro and in vivo studies of murine erythropoietic recovery after treatment with cyclophosphamide].
Aguirre MV; Juaristi JA; Alba Alvarez M; Carmuega RJ; Brandan NC
Sangre (Barc); 1999 Jun; 44(3):182-7. PubMed ID: 10481578
[TBL] [Abstract][Full Text] [Related]
37. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
[TBL] [Abstract][Full Text] [Related]
38. Effects of different intensities of extremely low frequency pulsed electromagnetic fields on formation of osteoclast-like cells.
Chang K; Chang WH; Wu ML; Shih C
Bioelectromagnetics; 2003 Sep; 24(6):431-9. PubMed ID: 12929162
[TBL] [Abstract][Full Text] [Related]
39. Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamide.
Tzai TS; Lin JS; Chow NH
J Surg Res; 1996 Oct; 65(2):139-44. PubMed ID: 8903460
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of 3,3'-Dimethylbenzidine Dihydrochloride (CAS No. 612-82-8) in F344/N Rats (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1991 Jun; 390():1-238. PubMed ID: 12637969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
